Bumili ng Transfidelity (FIDEL) sa Mexico

Transfidelity is a decentralized science project that aims to address neurodegenerative conditions like Alzheimers and Parkinsons at their biological source. The project is built on the scientific concept of protein translation fidelity, which involves ensuring that the proteins produced by cells are accurate and functional. As individuals age, their cellular machinery becomes more prone to errors, leading to misfolded proteins that aggregate and cause damage to brain cells. The primary goal of Transfidelity is to develop compounds that improve the accuracy of protein printing, effectively upgrading the quality control systems of the brain to prevent the formation of toxic protein clumps. This research is led by scientists Dr. Dimitri Scherbakov and Dr. Rashid Akbergenov, who have identified specific molecules with the potential to reduce cellular stress and maintain cognitive health. Within the Web3 ecosystem, the project utilizes the FIDEL token on the Base blockchain. This token serves as a governance and utility mechanism, allowing community members to vote on research priorities and participate in the development of the project. Transfidelity is closely associated with decentralized autonomous organizations like VitaDAO and Cerebrum DAO. These partnerships help facilitate the funding and translation of early stage neuroscience research into potential real world treatments. The project also makes use of blockchain specific technology such as Intellectual Property Non-Fungible Tokens and Intellectual Property Tokens. These assets allow for the representation and management of scientific intellectual property on the blockchain, creating a transparent way to track research milestones and ownership. By integrating biomedical research with decentralized governance, Transfidelity seeks to accelerate the pace of drug discovery and improve brain health outcomes globally through a collaborative, community driven model. Matuto pa